Arene-ruthenium complexes with ferrocene-derived ligands: Synthesis and characterization of complexes of the type [Ru(η6-arene)(NC5H4CH2NHOC-C5H4FeC5H5)Cl2] and [Ru(η6-arene)(NC3H3N(CH2)2O2C-C5H4FeC5H5)Cl2]

被引：47
作者：
Auzias, Mathieu [1 ]
Gueniat, Joeel [1 ]
Therrien, Bruno [1 ]
Suess-Fink, Georg [1 ]
Renfrew, Anna K. [2 ]
Dyson, Paul J. [2 ]
机构：
[1] Univ Neuchatel, Inst Chim, CH-2009 Neuchatel, Switzerland
[2] Ecole Polytech Fed Lausanne, Inst Sci & Ingn Chim, CH-1015 Lausanne, Switzerland
来源：
JOURNAL OF ORGANOMETALLIC CHEMISTRY | 2009年 / 694卷 / 06期
关键词：
Ruthenium; Anticancer agents; Bioorganometallic chemistry; Arene ligands; Ferrocene-derived ligands; ESTROGEN-RECEPTOR MODULATORS; PLASMA-MASS SPECTROMETRY; IN-VITRO; HUMAN SERUM; CAPILLARY-ELECTROPHORESIS; ANTICANCER ACTIVITY; PROTEIN-BINDING; NAMI-A; DNA; CANCER;
D O I：
10.1016/j.jorganchem.2008.08.012
中图分类号：
O61 [无机化学];
学科分类号：
070301 ; 081704 ;
摘要：
Arene-ruthenium complexes of general formula [Ru(eta(6)-arene)(L)Cl-2] where L=NC5H4CH2NHOC-C5H4FeC5H5, arene=p-(PrC6H4Me)-Pr-i (1) or C6Me6 (2); L=NC3H3N(CH2)(2)O2C-C5H4FeC5H5, arene=p-(PrC6H4Me)-Pr-i (3) or C6Me6 (4), and diruthenium-arene complexes of general formula [Ru(eta(6-)arene) Cl-2](2)(L) where L=1,1'-(NC5H4CH2NHOC)(2)-C5H4FeC5H4, arene=p-(PrC6H4Me)-Pr-i (5) or C6Me6 (6); L=1,1'-(NC3H3N(CH2)(2)O2C)(2)-C5H4FeC5H4, arene=p-(PrC6H4Me)-Pr-i (7) or C6Me6 (8) have been synthesized and characterized. The molecular structures of 1 and 3 were confirmed by single-crystal X-ray diffraction. The in vitro anticancer activities of complexes 1-8 have been studied comparatively to the uncoordinated ligands. The complexes exhibit fairly low cytotoxicities in comparison to related ferrocene-derived arene-ruthenium complexes. (C) 2008 Elsevier B. V. All rights reserved.
引用
收藏
页码：855 / 861
页数：7
相关论文
共 52 条
[1]   Ovarian cancer: Strategies for overcoming resistance to chemotherapy [J].
Agarwal, R ;
Kaye, SB .
NATURE REVIEWS CANCER, 2003, 3 (07) :502-516
[2]   The interactions of low oxidation state transition metal clusters with DNA: Potential applications in cancer therapy [J].
Allardyce, CS ;
Dyson, PJ .
JOURNAL OF CLUSTER SCIENCE, 2001, 12 (04) :563-569
[3]   [Ru(η6-p-cymene)Cl2(pta)] (pta=1,3,5-triaza-7-phosphatricyclo[3.3.1.1]decane):: a water soluble compound that exhibits pH dependent DNA binding providing selectivity for diseased cells [J].
Allardyce, CS ;
Dyson, PJ ;
Ellis, DJ ;
Heath, SL .
CHEMICAL COMMUNICATIONS, 2001, (15) :1396-1397
[4]   Organometallic ruthenium inhibitors of glutathione-S-transferase P1-1 as anticancer drugs [J].
Ang, Wee Han ;
De Luca, Anastasia ;
Chapuis-Bernasconi, Catherine ;
Juillerat-Jeanneret, Lucienne ;
Lo Bello, Mario ;
Dyson, Paul J. .
CHEMMEDCHEM, 2007, 2 (12) :1799-1806
[5]   Strategy to tether organometallic ruthenium-arene anticancer compounds to recombinant human serum albumin [J].
Ang, Wee Han ;
Daldini, Elisa ;
Juillerat-Jeanneret, Lucienne ;
Dyson, Paul J. .
INORGANIC CHEMISTRY, 2007, 46 (22) :9048-9050
[6]   Classical and non-classical ruthenium-based anticancer drugs: Towards targeted chemotherapy [J].
Ang, Wee Han ;
Dyson, Paul J. .
EUROPEAN JOURNAL OF INORGANIC CHEMISTRY, 2006, (20) :4003-4018
[7]   Ferrocenoyl pyridine arene ruthenium complexes with anticancer properties:: Synthesis, structure, electrochemistry, and cytotoxicity [J].
Auzias, Mathieu ;
Therrien, Bruno ;
Suess-Fink, Georg ;
Stepnicka, Petr ;
Ang, Wee Han ;
Dyson, Paul J. .
INORGANIC CHEMISTRY, 2008, 47 (02) :578-583
[8]   ARENE RUTHENIUM(II) COMPLEXES FORMED BY DEHYDROGENATION OF CYCLOHEXADIENES WITH RUTHENIUM(III) TRICHLORIDE [J].
BENNETT, MA ;
SMITH, AK .
JOURNAL OF THE CHEMICAL SOCIETY-DALTON TRANSACTIONS, 1974, (02) :233-241
[9]   (ETA-6-HEXAMETHYLBENZENE)RUTHENIUM COMPLEXES [J].
BENNETT, MA ;
HUANG, TN ;
MATHESON, TW ;
SMITH, AK .
INORGANIC SYNTHESES, 1982, 21 :74-78
[10]  
Boulikas T, 2003, ONCOL REP, V10, P1663
123456